Dr. Anant Sharma, M.D
NPI: 1154522209
Total Payments
$2,467
2024 Payments
$1,491
Companies
29
Transactions
66
Medicare Patients
20,485
Medicare Billing
$4.7M
Payment Breakdown by Category
Food & Beverage$1,631 (66.1%)
Other$797.60 (32.3%)
Education$38.87 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,631 | 55 | 66.1% |
| Long term medical supply or device loan | $797.60 | 8 | 32.3% |
| Education | $38.87 | 3 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $853.15 | 11 | $0 (2024) |
| PUMA BIOTECHNOLOGY, INC. | $246.54 | 3 | $0 (2024) |
| Celgene Corporation | $196.66 | 11 | $0 (2024) |
| Genentech USA, Inc. | $171.93 | 3 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $135.44 | 3 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $117.59 | 1 | $0 (2022) |
| Merck Sharp & Dohme LLC | $93.97 | 2 | $0 (2024) |
| Daiichi Sankyo Inc. | $78.61 | 4 | $0 (2024) |
| Incyte Corporation | $60.91 | 3 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $57.52 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,491 | 36 | Novartis Pharmaceuticals Corporation ($833.20) |
| 2023 | $77.16 | 4 | Janssen Biotech, Inc. ($24.93) |
| 2022 | $212.41 | 7 | Myriad Genetic Laboratories, Inc. ($117.59) |
| 2021 | $176.56 | 5 | PUMA BIOTECHNOLOGY, INC. ($113.25) |
| 2020 | $17.18 | 1 | Lilly USA, LLC ($17.18) |
| 2019 | $116.01 | 2 | E.R. Squibb & Sons, L.L.C. ($101.31) |
| 2018 | $105.07 | 3 | Merck Sharp & Dohme Corporation ($69.33) |
| 2017 | $272.49 | 8 | Genentech USA, Inc. ($171.93) |
All Payment Transactions
66 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: Oncology | ||||||
| 12/17/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $27.69 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $16.11 | General |
| Category: Hematology | ||||||
| 12/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Oncology | ||||||
| 11/22/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $124.64 | General |
| 11/21/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $8.65 | General |
| 11/19/2024 | PFIZER INC. | IBRANCE (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Oncology | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $14.83 | General |
| Category: Oncology | ||||||
| 11/08/2024 | Agios Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $13.27 | General |
| 10/31/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $33.06 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ICLUSIG (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: ONCOLOGY | ||||||
| 10/22/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $23.19 | General |
| 10/22/2024 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: CELLT | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 10/15/2024 | ARRAY BIOPHARMA INC | XALKORI (Drug), LORBRENA, BRAFTOVI | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: ONCOLOGY | ||||||
| 10/08/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: Oncology | ||||||
| 10/03/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $25.95 | General |
| 09/27/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 09/26/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $26.89 | General |
| Category: Hematology/Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 66 | 5,256 | 93,345 | $4.4M | $952,187 |
| 2022 | 78 | 5,641 | 98,652 | $6.5M | $1.2M |
| 2021 | 67 | 4,756 | 113,743 | $5.3M | $1.2M |
| 2020 | 82 | 4,832 | 131,402 | $6.5M | $1.3M |
Total Patients
20,485
Total Services
437,142
Medicare Billing
$4.7M
Procedure Codes
293
All Medicare Procedures & Services
293 procedure records from CMS Medicare Utilization — Page 1 of 12
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2023 | 18 | 10,200 | $1.4M | $440,584 | 31.6% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 53 | 84 | $403,368 | $92,058 | 22.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 18 | 4,680 | $306,600 | $86,139 | 28.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 345 | 812 | $298,816 | $73,340 | 24.5% |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 2023 | 26 | 10,315 | $206,300 | $24,248 | 11.8% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 81 | 252 | $178,164 | $23,751 | 13.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 303 | 387 | $96,750 | $21,930 | 22.7% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 84 | 109 | $116,303 | $18,172 | 15.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 537 | 1,458 | $93,312 | $15,019 | 16.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 579 | 1,495 | $29,900 | $12,480 | 41.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 576 | 1,611 | $57,996 | $12,181 | 21.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 99 | 99 | $55,935 | $11,714 | 20.9% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2023 | 60 | 94 | $61,758 | $8,444 | 13.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 79 | 175 | $54,775 | $8,069 | 14.7% |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 2023 | 22 | 17,850 | $89,250 | $7,035 | 7.9% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 16 | 123 | $25,953 | $6,653 | 25.6% |
| 71260 | Ct scan of chest with contrast | Office | 2023 | 97 | 129 | $105,909 | $6,397 | 6.0% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 244 | 418 | $25,080 | $5,559 | 22.2% |
| 85055 | Reticulated (young) platelet measurement | Office | 2023 | 71 | 160 | $22,880 | $5,539 | 24.2% |
| G0498 | Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | Office | 2023 | 14 | 43 | $21,500 | $5,326 | 24.8% |
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 2023 | 14 | 19 | $52,478 | $5,161 | 9.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 37 | 40 | $19,840 | $5,115 | 25.8% |
| M0010 | Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Office | 2023 | 15 | 67 | $4,690 | $4,714 | 100.5% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 80 | 385 | $41,580 | $4,278 | 10.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 24 | 24 | $17,016 | $3,901 | 22.9% |
About Dr. Anant Sharma, M.D
Dr. Anant Sharma, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Denton, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1154522209.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anant Sharma, M.D has received a total of $2,467 in payments from pharmaceutical and medical device companies, with $1,491 received in 2024. These payments were reported across 66 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($1,631).
As a Medicare-enrolled provider, Sharma has provided services to 20,485 Medicare beneficiaries, totaling 437,142 services with total Medicare billing of $4.7M. Data is available for 4 years (2020–2023), covering 293 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Internal Medicine, Hematology & Oncology
- Location Denton, TX
- Active Since 05/29/2007
- Last Updated 08/18/2014
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1154522209
Products in Payments
- KISQALI (Drug) $831.77
- Perjeta (Biological) $171.93
- PreciseTumor (Device) $117.59
- NERLYNX (Drug) $113.25
- EMPLICITI (Biological) $101.31
- Abraxane (Drug) $100.56
- KEYTRUDA (Biological) $93.97
- Enhertu (Drug) $78.61
- REBLOZYL (Biological) $48.25
- JAKAFI (Drug) $42.15
- FRUZAQLA (Drug) $39.52
- IBRANCE (Drug) $38.47
- Da Vinci Surgical System (Device) $37.48
- PROVENGE (Drug) $33.06
- Pomalyst (Drug) $31.95
- Lenvima (Drug) $25.15
- DARZALEX (Biological) $24.93
- Stivarga (Drug) $23.38
- PLUVICTO (Drug) $21.38
- LYNPARZA (Drug) $20.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Denton
Folahan Ayoola, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $550,100
Student in an Organized Health Care Education/Training Program $550,100
Dr. Diana Castro, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $390,836
Student in an Organized Health Care Education/Training Program $390,836
Shikha Mane, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $9,015
Student in an Organized Health Care Education/Training Program $9,015
Dr. Bryan David, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $8,244
Student in an Organized Health Care Education/Training Program $8,244
Geoffrey Gibson, Do, DO
Student in an Organized Health Care Education/Training Program — Payments: $3,180
Student in an Organized Health Care Education/Training Program $3,180
Hans Drawbert, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $1,968
Student in an Organized Health Care Education/Training Program $1,968